[Molecular targeting agents for multiple myeloma]

Nihon Rinsho. 2012 Nov:70 Suppl 8:518-23.
[Article in Japanese]
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Boron Compounds / therapeutic use
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Glycine / analogs & derivatives
  • Glycine / therapeutic use
  • Histone Deacetylases / therapeutic use*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lactones / therapeutic use
  • Lenalidomide
  • Molecular Targeted Therapy / methods*
  • Multiple Myeloma / drug therapy*
  • Oligopeptides / therapeutic use
  • Proteasome Inhibitors / therapeutic use*
  • Pyrazines / therapeutic use
  • Pyrroles / therapeutic use
  • Thalidomide / analogs & derivatives
  • Thalidomide / therapeutic use

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Boron Compounds
  • Boronic Acids
  • Immunologic Factors
  • Lactones
  • Oligopeptides
  • Proteasome Inhibitors
  • Pyrazines
  • Pyrroles
  • elotuzumab
  • Thalidomide
  • Bortezomib
  • marizomib
  • ixazomib
  • carfilzomib
  • Histone Deacetylases
  • Lenalidomide
  • Glycine